UPM Institutional Repository

Premutation Females with preFXTAS


Citation

Liani, Valentina and Torrents, Carme and Rolleri, Elisa and Yusoff, Nor Azyati and Likhitweerawong, Narueporn and Moore, Sydney and Tassone, Flora and Schneider, Andrea and Santos, Ellery and Biag, Hazel M. B. and Bourgeois, James A. and Unruh, Kathryn E. and Mosconi, Matthew W. and Hagerman, Randi J. (2025) Premutation Females with preFXTAS. International Journal of Molecular Sciences, 26 (6). art. no. 2825. pp. 1-20. ISSN 1661-6596; eISSN: 1422-0067

Abstract

Fragile-X-associated tremor/ataxia syndrome (FXTAS) is a progressive neurodegenerative disorder associated with the FMR1 gene premutation, characterized by the presence of 55 to 200 CGG triplet repeat expansions. Although the initial symptoms of FXTAS typically manifest in males around the age of 60 with motor symptoms and cognitive deficits, the presentation and progression in females differ. Women, in fact, exhibit a higher prevalence of neuropsychiatric symptoms, with an earlier onset compared to the motor symptoms observed in men. The following article reports on ten cases of women with a diagnosis of FMR1 gene premutation, originating from two medical centers. All the women in the study exhibited neuropsychiatric symptoms and subtle neurological signs as common features. Symptoms typically observed in the male population, such as tremors and cerebellar ataxia, were either absent or significantly reduced in the female cohort. Conversely, there was a higher prevalence of neuropsychiatric symptoms among the women. Neurocognitive impairment was only minimally evident, with mild executive dysfunction and memory complaints noted in a subset of cases. For this reason, we propose the terminology preFXTAS or prodromic FXTAS to define a clinical presentation in women characterized by early manifestations of FXTAS that do not entirely fulfill the established diagnostic criteria but exhibit MRI evidence of white matter alterations suggesting the initiation of the disease process. The study underscores the importance of establishing new diagnostic criteria for FXTAS and, at the same time, developing new biomarkers and interview checklists/assessment scales dedicated to females.


Download File

[img] Text
122006.pdf - Published Version
Available under License Creative Commons Attribution.

Download (1MB)
Official URL or Download Paper: https://www.mdpi.com/1422-0067/26/6/2825

Additional Metadata

Item Type: Article
Divisions: Faculty of Medicine and Health Science
DOI Number: https://doi.org/10.3390/ijms26062825
Publisher: Multidisciplinary Digital Publishing Institute (MDPI)
Keywords: Fmr1 gene; FXTAS; Neurological problems; Neuropsychiatric problems; Premutation
Depositing User: Ms. Che Wa Zakaria
Date Deposited: 30 Dec 2025 08:15
Last Modified: 30 Dec 2025 08:15
Altmetrics: http://www.altmetric.com/details.php?domain=psasir.upm.edu.my&doi=10.3390/ijms26062825
URI: http://psasir.upm.edu.my/id/eprint/122006
Statistic Details: View Download Statistic

Actions (login required)

View Item View Item